Smart T-Shirt Piloted at Leicester to Support Diagnosis of Breathing Pattern Disorders

Why It Matters

If validated, the smart shirt could provide a comfortable, low‑cost alternative for diagnosing breathing disorders, accelerating the adoption of wearable health tech across the NHS and private clinics.

Key Takeaways

• Anasa Smart Shirt monitors breathing via sternum and abdomen sensors
• Trial compares data to motion‑capture gold standard for accuracy
• Wearable could offer cheaper, comfortable alternative for breathing disorder diagnosis
• UK invests $767 M in digital pathology, signaling broader diagnostic tech push
• MHRA offers $1,250 regulatory advice hour for medical device makers

Pulse Analysis

The Anasa® Smart Shirt, developed by Atride, embeds nanotech‑enabled sensor bands across the sternum and abdomen to capture continuous respiratory waveforms. In a pilot at the NIHR Leicester Biomedical Research Centre, patients wear the virtually invisible garment while clinicians compare its output to the current gold‑standard motion‑capture photography. Early results suggest the wearable can detect subtle changes in breathing pattern that often elude traditional spirometry, offering a more comfortable, ambulatory alternative that could streamline the diagnosis of breathing pattern disorders such as dysfunctional breathing or hyperventilation syndrome.

The Leicester study arrives amid a wave of UK investment in digital diagnostics. 78 million) to advance AI‑driven blood‑cancer analysis, while the government’s National Cancer Plan earmarks £604 million (≈$767 million) for digital pathology and £96 million (≈$122 million) to automate histopathology workflows. These funds reflect a strategic push to replace manual, time‑intensive tests with data‑rich, algorithmic solutions, creating a fertile environment for wearable technologies that can feed real‑time physiological data into broader diagnostic ecosystems. Regulatory clarity will be key to scaling such devices.

The MHRA’s new advisory service, priced at £987 (≈$1,250) per hour, offers manufacturers direct guidance on navigating complex medical‑device rules, a move that could accelerate market entry for wearables like the Anasa shirt. By aligning clinical validation with regulatory expectations early, companies can reduce time‑to‑market and reassure NHS procurement bodies. If the pilot confirms parity with motion‑capture standards, the smart t‑shirt could become a cost‑effective tool for primary‑care clinics, expanding the reach of precision respiratory diagnostics across the UK.